Sean D Sullivan Selected Research

Enoxaparin (Lovenox)

3/2006	Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery.
1/2004	A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sean D Sullivan Research Topics

Disease

20	Neoplasms (Cancer) 09/2023 - 12/2006
15	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2006
13	Asthma (Bronchial Asthma) 01/2018 - 09/2003
10	Pain (Aches) 09/2015 - 11/2006
8	Febrile Neutropenia 09/2023 - 03/2009
7	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 09/2010
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2010 - 03/2004
5	Emphysema 01/2009 - 05/2003
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2023 - 01/2012
4	Rheumatoid Arthritis 01/2018 - 01/2011
4	Spinal Stenosis (Stenosis, Spinal) 09/2015 - 03/2012
4	Breast Neoplasms (Breast Cancer) 01/2014 - 03/2009
4	Chronic Hepatitis B 03/2008 - 01/2007
3	Obesity 01/2024 - 11/2006
3	Weight Loss (Weight Reduction) 07/2022 - 11/2006
3	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 07/2013
3	Respiratory Tract Infections (Respiratory Tract Infection) 03/2018 - 05/2004
3	Infections 05/2012 - 05/2009
3	Alzheimer Disease (Alzheimer's Disease) 05/2011 - 01/2011
3	Disease Progression 08/2007 - 01/2004
3	Fibrosis (Cirrhosis) 01/2007 - 01/2004
2	Overweight 01/2024 - 07/2022
2	Atopic Dermatitis (Atopic Eczema) 01/2023 - 12/2017
2	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 06/2022
2	Chronic Renal Insufficiency 01/2022 - 12/2021
2	Lung Neoplasms (Lung Cancer) 08/2020 - 07/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 12/2018
2	Morbid Obesity 01/2018 - 04/2014
2	Low Back Pain (Lumbago) 09/2015 - 08/2013
2	Myocardial Infarction 02/2015 - 05/2002
2	Migraine Disorders (Migraine) 12/2013 - 07/2013
2	Rheumatic Diseases (Rheumatism) 11/2013 - 01/2013
2	Headache (Headaches) 07/2013 - 07/2011
2	Overactive Urinary Bladder (Overactive Bladder) 10/2010 - 11/2009
2	Diabetes Complications 11/2009 - 02/2009
2	Stroke (Strokes) 01/2008 - 05/2002
2	Venous Thromboembolism 03/2006 - 01/2004
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 09/2005 - 10/2004
2	Pneumonia (Pneumonitis) 07/2004 - 05/2004
1	COVID-19 12/2023
1	Hemorrhage 06/2023
1	Hemophilia A (Haemophilia) 06/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Brain Neoplasms (Brain Tumor) 10/2022
1	Thyroid Neoplasms (Thyroid Cancer) 06/2022

Drug/Important Bio-Agent (IBA)

8	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 09/2023 - 09/2010
7	larotrectinibIBA 01/2023 - 08/2020
7	Insulin (Novolin)FDA Link 01/2022 - 11/2016
7	Insulin Glargine (Lantus)FDA Link 01/2022 - 11/2016
7	SteroidsIBA 08/2013 - 12/2003
4	Opioid Analgesics (Opioids)IBA 02/2015 - 12/2006
4	Type A Botulinum Toxins (Botox)FDA Link 07/2013 - 11/2009
4	Lamivudine (Epivir)FDA Link 03/2008 - 01/2007
4	Hepatitis B e AntigensIBA 03/2008 - 01/2007
3	Phosphotransferases (Kinase)IBA 01/2023 - 01/2022
3	entrectinibIBA 10/2022 - 08/2020
3	insulin degludecIBA 01/2021 - 01/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 05/2002
3	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2015 - 10/2004
3	Methotrexate (Mexate)FDA LinkGeneric 03/2015 - 01/2011
3	ORALIT (ORS)IBA 12/2013 - 09/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013 - 01/2013
3	Budesonide (Pulmicort)FDA LinkGeneric 05/2006 - 12/2003
2	Antiviral Agents (Antivirals)IBA 12/2023 - 03/2011
2	TropomyosinIBA 01/2023 - 01/2022
2	tyrosine receptor (receptor, tyrosine)IBA 01/2022 - 01/2022
2	finerenoneIBA 01/2022 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
2	Insulin Detemir (Levemir)FDA Link 01/2022 - 01/2018
2	InsulinsIBA 01/2020 - 11/2016
2	axicabtagene ciloleucelIBA 01/2019 - 12/2018
2	Glucose (Dextrose)FDA LinkGeneric 11/2016 - 11/2006
2	pegfilgrastim (Neulasta)FDA Link 01/2012 - 03/2009
2	Muscarinic AntagonistsIBA 10/2010 - 11/2009
2	glimepiride (Amarel)FDA LinkGeneric 11/2009 - 02/2009
2	Liraglutide FDA Link 11/2009 - 02/2009
2	Fondaparinux (Arixtra)FDA Link 03/2006 - 01/2004
2	Enoxaparin (Lovenox)FDA LinkGeneric 03/2006 - 01/2004
2	Clarithromycin (Biaxin)FDA LinkGeneric 07/2004 - 05/2004
2	telithromycin (Ketek)FDA Link 07/2004 - 05/2004
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2024
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2024
1	nirmatrelvir and ritonavir drug combinationIBA 12/2023
1	Factor VIII (Coagulation Factor VIII)IBA 06/2023
1	ruxolitinibIBA 01/2023
1	Janus Kinase InhibitorsIBA 01/2023
1	CholesterolIBA 07/2022
1	semaglutideIBA 07/2022

Therapy/Procedure

36	Therapeutics 01/2023 - 05/2003
14	Drug Therapy (Chemotherapy) 09/2023 - 05/2002
7	Injections 09/2015 - 11/2006
5	Pneumonectomy (Lung Volume Reduction) 01/2009 - 05/2003
4	Standing Orders 01/2023 - 11/2019
2	Glycemic Control 01/2020 - 07/2013
2	Bariatric Surgery 01/2018 - 04/2014
2	Epidural Injections 07/2014 - 03/2012
2	Episode of Care 04/2014 - 07/2009
2	Biological Therapy 04/2014 - 01/2011
2	Hospice Care (Care, Bereavement) 01/2008 - 12/2006
2	Secondary Prevention 09/2007 - 05/2002